Literature DB >> 29804489

Acute effects of multi-walled carbon nanotubes on primary bronchial epithelial cells from COPD patients.

Seraina Beyeler1,2, Savvina Chortarea3,4, Barbara Rothen-Rutishauser3, Alke Petri-Fink3, Peter Wick4, Stefan A Tschanz5, Christophe von Garnier1,2, Fabian Blank1,2.   

Abstract

The risks of occupational exposure during handling of multi-walled carbon nanotubes (MWCNTs) have received limited attention to date, in particular for potentially susceptible individuals with highly prevalent chronic obstructive pulmonary disease (COPD). In this in vitro study, we simulated acute inhalation of MWCNTs employing an air-liquid interface cell exposure (ALICE) system: primary human bronchial epithelial cells from COPD patients and healthy donors (controls), cultured at the air-liquid interface (ALI) were exposed to MWCNTs. To study acute health effects on the respiratory epithelium, two different concentrations (0.16; 0.34 µg/cm2) of MWCNTs were aerosolized onto cell cultures followed by analysis after 24 h. Following MWCNT exposure, epithelial integrity and differentiation remained intact. Electron microscopy analyses identified MWCNTs both extra- and intracellular within vesicles of mucus producing cells. In both COPD and healthy control cultures, MWCNTs neither caused increased release of lactate dehydrogenase (LDH), nor alterations in inflammatory responses, as measured by RNA expression and protein secretion of the cytokines IL-6, IL-8, CXCL10, IL-1β and TGF-β and oxidative stress markers HMOX-1 and SOD-2. No short-term alteration of epithelial cell function, as determined by ciliary beating frequency (CBF), occurred in any of the conditions tested. In conclusion, the present study provided a reliable and realistic in vitro acute-exposure model of the respiratory tract, responsive to positive controls such as Dörentruper Quartz (DQ12) and asbestos. Acute exposure to MWCNTs did not affect epithelial integrity, nor induce increased cell death, apoptosis or inflammatory changes.

Entities:  

Keywords:  Exposure; air–liquid interface cell exposure system; fiber toxicology; nanoparticles; nanotubes

Mesh:

Substances:

Year:  2018        PMID: 29804489     DOI: 10.1080/17435390.2018.1472310

Source DB:  PubMed          Journal:  Nanotoxicology        ISSN: 1743-5390            Impact factor:   5.913


  5 in total

Review 1.  Innovative preclinical models for pulmonary drug delivery research.

Authors:  Stephan Ehrmann; Otmar Schmid; Chantal Darquenne; Barbara Rothen-Rutishauser; Josue Sznitman; Lin Yang; Hana Barosova; Laurent Vecellio; Jolyon Mitchell; Nathalie Heuze-Vourc'h
Journal:  Expert Opin Drug Deliv       Date:  2020-02-23       Impact factor: 6.648

2.  A Device for measuring the in-situ response of Human Bronchial Epithelial Cells to airborne environmental agents.

Authors:  Lakshmana D Chandrala; Nima Afshar-Mohajer; Kristine Nishida; Yury Ronzhes; Venkataramana K Sidhaye; Kirsten Koehler; Joseph Katz
Journal:  Sci Rep       Date:  2019-05-13       Impact factor: 4.379

3.  An In Vitro Lung System to Assess the Proinflammatory Hazard of Carbon Nanotube Aerosols.

Authors:  Hana Barosova; Bedia Begum Karakocak; Dedy Septiadi; Alke Petri-Fink; Vicki Stone; Barbara Rothen-Rutishauser
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

4.  On-Site Deployment of an Air-Liquid-Interphase Device to Assess Health Hazard Potency of Airborne Workplace Contaminants: The Case of 3-D Printers.

Authors:  Boowook Kim; Jae Hoon Shin; Hoi Pin Kim; Mi Seong Jo; Hee Sang Kim; Jong Sung Lee; Hong Ku Lee; Hyuk Cheol Kwon; Sung Gu Han; Noeul Kang; Mary Gulumian; Dhimiter Bello; Il Je Yu
Journal:  Front Toxicol       Date:  2022-03-25

Review 5.  Invited review: human air-liquid-interface organotypic airway tissue models derived from primary tracheobronchial epithelial cells-overview and perspectives.

Authors:  Xuefei Cao; Jayme P Coyle; Rui Xiong; Yiying Wang; Robert H Heflich; Baiping Ren; William M Gwinn; Patrick Hayden; Liying Rojanasakul
Journal:  In Vitro Cell Dev Biol Anim       Date:  2020-11-11       Impact factor: 2.723

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.